Evaluation of Biomarkers of Traumatic Brain Injury

CompletedOBSERVATIONAL
Enrollment

2,011

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Traumatic Brain Injury
Interventions
OTHER

Head CT scan and blood draw within 12 hours of injury

Trial Locations (24)

6725

University of Szeged, Albert Szent Gyorgi Medical Center, Szeged

7623

University of Pecs, Pécs

14642

University of Rochester Medical Center, Rochester

15213

University of Pittsburgh, Pittsburgh

22908

University of Virginia, Charlottesville

23298

Virginia Commonwealth University, Richmond

24073

Carilion New River Valley, Christiansburg

27599

University of North Carolina at Chapel Hill, Chapel Hill

32308

Tallahassee Neurological Clinic, Tallahassee

32610

University of Florida, Gainesville

48201

Wayne State University - Detroit Receiving Hospital, Detroit

48235

Wayne State University - Sinai Grace Hospital, Detroit

63110

Washington University, St Louis

77030

Baylor College of Medicine/Ben Taub General Hospital, Houston

78701

University Medical Center Brackenridge, Austin

92103

University of California San Diego, San Diego

98104

University of Washington, Seattle

06102

Hartford Hospital, Hartford

01655

University of Massachusetts Medical School, Worcester

D-12200

Charité Universitätsmedizin Berlin - Campus Benjamin Franklin, Berlin

D-13353

Charité Universitätsmedizin Berlin - Campus Virchow Klinikum, Berlin

DE-69120

University of Heidelberg, Heidelberg

DE-80336

Ludwig-Maximilians-University, Munich

DE-81675

Klinikum rechts der Isar of the Technical University of Munich, Munich

Sponsors
All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Banyan Biomarkers, Inc

INDUSTRY

NCT01426919 - Evaluation of Biomarkers of Traumatic Brain Injury | Biotech Hunter | Biotech Hunter